JP Morgan Chase’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-25,300
Closed -$399K 6775
2022
Q2
$399K Buy
+25,300
New +$425K ﹤0.01% 4705
2018
Q4
Sell
-11,000
Closed -$188K 5886
2018
Q3
$188K Buy
+11,000
New +$189K ﹤0.01% 4711
2016
Q3
Sell
-21,000
Closed -$448K 4744
2016
Q2
$448K Buy
+21,000
New +$396K ﹤0.01% 3467
2015
Q4
Sell
-180,000
Closed -$2.37M 4789
2015
Q3
$2.37M Buy
180,000
+35,000
+24% +$555K ﹤0.01% 2651
2015
Q2
$2.73M Hold
145,000
﹤0.01% 2732
2015
Q1
$2.72M Sell
145,000
-70,000
-33% -$1.2M ﹤0.01% 2720
2014
Q4
$3.57M Sell
215,000
-25,000
-10% -$527K ﹤0.01% 2623
2014
Q3
$7.81M Buy
+240,000
New +$8.15M ﹤0.01% 2084

Other funds holding PTEN

JP Morgan Chase's PTEN Position: Q1 2026 in Review

JP Morgan Chase increased its Patterson-UTI (PTEN) stake by 39% in Q1 2026, buying an estimated $5.5M and bringing the position to 2,271,829 shares worth $25.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1901.

JP Morgan Chase first reported a position in PTEN in Q2 2013 and has held it in 52 quarters since. The position peaked at $195M in Q4 2017. 410 funds tracked by Wall St. Rank hold PTEN as of Q1 2026.

  • JP Morgan Chase held 2,271,829 shares of Patterson-UTI worth $25.1M as of Q1 2026.
  • JP Morgan Chase bought 642,552 Patterson-UTI shares in Q1 2026, an estimated $5.5M.
  • Patterson-UTI made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #1901 holding.
  • JP Morgan Chase first reported a position in Patterson-UTI in Q2 2013 and has held it in 52 quarters since.
  • JP Morgan Chase's Patterson-UTI position peaked at $195M in Q4 2017.
  • 410 funds tracked by Wall St. Rank held Patterson-UTI as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.